CS DIAGNOSTICS CORP. 8-K

What Happened
On June 23, 2026, CS Diagnostics Corp. (CSDX) filed an 8‑K reporting that its Board concluded previously issued financial statements for the fiscal years ended December 31, 2022, 2023, 2024 and 2025 (and related interim filings) should no longer be relied upon. Management preliminarily concluded that an approximately $499.4 million intangible asset recorded in connection with a September 4, 2023 transaction was improperly recognized and likely must be removed. The Board directed management to restate the affected financial statements, engaged technical accounting advisor KBF Advisory LLC and new independent auditor Shah Teelani & Associates LLC to assist with re‑audits and filings, and expects to file restated statements with its Form 10‑K for 2025.

Key Details

• Affected periods: fiscal years ended Dec 31, 2022, 2023, 2024 and 2025, plus interim filings for those periods.
• Material item: ~ $499.4 million intangible asset recorded Sept 4, 2023, now preliminarily considered improperly recognized.
• Auditors/advisors: engaged KBF Advisory LLC (technical accounting advisor) and Shah Teelani & Associates LLC (new independent registered public accounting firm) to re‑audit affected periods. Prior auditor Olayinka Oyebola & Co. is subject to SEC/regulatory restrictions, and reports from that firm are no longer relied upon.
• Expected impact/timing: removal of the intangible is expected to require restatements that will materially reduce reported total assets and stockholders’ equity; company intends to file restated financials with its 2025 Form 10‑K and will provide updates, including at a planned shareholder meeting.

Why It Matters
This filing signals a material correction to CSDX’s past financial reporting that could significantly change the company’s balance sheet, equity and related disclosures. For investors, restatements and auditor re‑work can affect the company’s financial metrics, investor confidence, and the timing of regulatory filings. The company has engaged advisors and a new auditor and says it will proceed promptly, but the final financial impact and timing will depend on the ongoing reviews and re‑audit results.